Stillcanna Produces Premium Grade CBD Isolate in Poland Stillcanna Produces Premium Grade CBD Isolate in Poland
Monday, October 21, 2019 12:43 PM
Stillcanna's Nexus Facility Produces Pharmaceutical Grade CBD Isolate in Poland
VANCOUVER, BC / ACCESSWIRE / Monday October 21, 2019 / Stillcanna Inc. (OTC:SCNNF) (CSE:STIL) (FRANKFURT:A2PEWA) ("STIL" or the "Company") is pleased to announce that its NEXUS extraction facility has produced bulk CBD isolate from hemp harvested by Olimax, the Company's farming subsidiary in Poland.
With the use of Stillcanna's proprietary operating procedures, CBD rich honey oil distillate is further purified into pharmaceutical grade CBD isolate. The successful manufacturing of the CBD isolate in the NEXUS facility is THC, pesticide and heavy metal free.
The Company is expected to begin shipping samples of its pharmaceutical grade CBD isolate to its current and potential customers as a part of its standard sales process this quarter. The Company is still on track for commercial production of CBD this quarter to begin fulfilling its contractual agreements.
CBD Isolate Manufactured at NEXUS, Stillcanna's Polish Extraction Facility
"The mandate of our Polish operations has always been seed to CBD, today we have achieved this goal", stated Jason Dussault CEO of Stillcanna. "I have always been proud of our team who continues to deliver, and today is no exception. With pharmaceutical grade CBD isolate in hand we can move to the final phase of delivery and sales."